[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:insulin-autoantibody":3},{"name":4,"total":5,"recruiting":6,"trials":7},"Insulin Autoantibody",6,4,[8,15,21,27,34,42],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT07155252","Home-based Oral Glucose Tolerance Test for Type 1 Diabetes Screening",[],"RECRUITING","2026-08-26T02:16:36.513735Z","2026-05-13T02:55:06.660720Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT05482321","Pancreas Ultrasound Imaging in type1 Diabetes",[],"2026-08-26T02:15:43.339060Z","2026-05-13T02:55:06.350832Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT05505669","Circulating Biomarkers in the Development of Type 1 Diabetes",[],"2026-08-26T02:16:11.347936Z","2026-05-13T02:55:06.352267Z",{"nct_id":28,"title":29,"phases":30,"status":12,"updated_at":32,"content_modified":33},"NCT07187531","SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes",[31],"Phase 2","2026-08-26T02:18:26.932189Z","2026-05-05T02:43:29.491704Z",{"nct_id":35,"title":36,"phases":37,"status":39,"updated_at":40,"content_modified":41},"NCT07670650","PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study",[38],"Phase 3","NOT_YET_RECRUITING","2026-08-26T02:15:02.712396Z","2026-07-05T03:45:20.372174Z",{"nct_id":43,"title":44,"phases":45,"status":46,"updated_at":47,"content_modified":48},"NCT06111586","FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)",[31],"ACTIVE_NOT_RECRUITING","2026-08-03T02:11:04.414058Z","2026-05-05T02:43:29.482368Z"]